Vanda Pharmaceuticals Inc. (VNDA) financial statements (2021 and earlier)

Company profile

Business Address 2200 PENNSYLVANIA AVE NW
WASHINGTON, DC 20037
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments312257143141143130130
Cash and cash equivalents45613440516165
Short-term investments267196110101926966
Receivables262918201642
Inventory, net of allowances, customer advances and progress billings111115
Inventory111115 
Prepaid expense   2533
Other current assets  3200 
Other undisclosed current assets1512580 1
Total current assets:354299170174167142136
Noncurrent Assets
Inventory, Noncurrent33322  
Property, plant and equipment4455522
Intangible assets, net (including goodwill)2325262839275
Intangible assets, net (excluding goodwill)2325262839275
Restricted cash and investments     11
Other noncurrent assets     0 
Other undisclosed noncurrent assets1001111  
Total noncurrent assets:13033363647308
TOTAL ASSETS:484332205210213172143
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:282220161686
Accounts payable     11
Accrued liabilities13101091275
Employee-related liabilities7654000
Other undisclosed accounts payable and accrued liabilities86533  
Deferred revenue and credits   027
Other liabilities     0 
Other undisclosed current liabilities3231503436(0)(0)
Total current liabilities:6053705051833
Noncurrent Liabilities
Liabilities, other than long-term debt14444366
Deferred revenue and credits   366
Other liabilities14444  
Other undisclosed noncurrent liabilities12  2525  
Total noncurrent liabilities:13442929366
Total liabilities:73577479801199
Stockholders' equity
Stockholders' equity attributable to parent41127513113113316144
Common stock0000000
Additional paid in capital631612493477461449355
Accumulated other comprehensive income (loss)00(0)0000
Accumulated deficit(221)(336)(361)(346)(328)(288)(311)
Total stockholders' equity:41127513113113316144
TOTAL LIABILITIES AND EQUITY:484332205210213172143

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues2271931651461105034
Revenue, net1651461105034
Cost of revenue(24)(21)(18)(25)(23)(2) 
Cost of goods and services sold    (23)(2) 
Gross profit:203173147121864934
Operating expenses(180)(151)(164)(140)(127)(29)(54)
Other undisclosed operating income      0
Operating income (loss):2322(17)(19)(40)20(20)
Nonoperating expense
(Investment Income, Nonoperating)
     (0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes6411   
Income (loss) from continuing operations before equity method investments, income taxes:2925(15)(18)(40)20(21)
Other undisclosed income from continuing operations before income taxes      0
Income (loss) from continuing operations before income taxes:2925(15)(18)(40)20(20)
Income tax expense (benefit)87(0)(0)(0)   
Net income (loss):11625(16)(18)(40)20(20)
Other undisclosed net income attributable to parent    00 
Net income (loss) available to common stockholders, diluted:11625(16)(18)(40)20(20)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):11625(16)(18)(40)20(20)
Other comprehensive income (loss)00(0)00(0)0
Comprehensive income (loss):11625(16)(18)(40)20(20)
Other undisclosed comprehensive income, net of tax, attributable to parent    00 
Comprehensive income (loss), net of tax, attributable to parent:11625(16)(18)(40)20(20)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: